Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03970616
Title A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma
Acronym DEDUCTIVE
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AVEO Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Duarte California 91010 United States Details
University of California - Irvine Orange California 92868 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
The University of Texas Health Science Center at Houston (UTHealth) Houston Texas 77030 United States Details
The University of Texas Health Science Center at Tyler (UTHealth) Tyler Texas 75708 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field